Radiology Groups Push Back on New Cancer Screening Guidelines - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Radiology Groups Push Back on New Cancer Screening Guidelines

Radiology groups say the ACP's new screening recommendations conflict with nearly every major cancer organization and could cost thousands of lives annually.

  • By

  • Kerri Miller

  • April 17, 2026

  • 2 min

Share

Objective:

To address the concerns raised by radiology organizations regarding the updated breast cancer screening guidelines released by the American College of Physicians (ACP).

Approach:
    Key Findings:
    • The ACP's recommendations could lead to an estimated 10,000 additional breast cancer deaths annually in the US.
    • The ACR and SBI's position aligns with multiple national cancer organizations advocating for earlier and more frequent screenings.
    • Claims of overdiagnosis and false positives in the ACP's guidance are considered overstated by the radiology groups.
    Interpretation:

    The pushback from ACR and SBI highlights significant disagreement within the medical community regarding breast cancer screening protocols, emphasizing the importance of early detection.

    Limitations:
    • The ACP guidelines apply only to average-risk, asymptomatic patients.
    • The debate does not encompass the full spectrum of breast cancer risk factors and patient demographics.
    Conclusion:

    The ACR and SBI urge clinicians to continue annual screening practices despite the ACP's new guidelines, reflecting a broader consensus among various cancer organizations.

Original Source(s)

Radiology Groups Push Back on New Cancer Screening Guidelines

  • by Kerri Miller

  • April 17, 2026

Related Content

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

Consensus Panel Calls for Enhanced Radiation Shielding

A consensus statement called for immediate adoption of enhanced radiation protection devices, although evidence of long-term health benefits and effectiveness across procedural settings remains limited.

Narrow DCIS Margins May Not Always Warrant Reexcision

An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.